We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
38 hedge funds and large institutions have $46.6M invested in Arcturus Therapeutics in 2014 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 7
34% more call options, than puts
Call options by funds: $52.5M | Put options by funds: $39.1M
23% more funds holding
Funds holding: 31 → 38 (+7)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
23% less capital invested
Capital invested by funds: $60.3M → $46.6M (-$13.6M)
53% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 15
Holders
38
Holders Change
+7
Holders Change %
+22.58%
% of All Funds
1.1%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
14
Increased
7
Reduced
15
Closed
7
Calls
$52.5M
Puts
$39.1M
Net Calls
+$13.4M
Net Calls Change
+$14.2M
Top Buyers
| 1 |
GL
GLG LLC
New York
|
+$4.47M |
| 2 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$2.42M |
| 3 |
Millennium Management
New York
|
+$1.63M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$781K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$655K |
Top Sellers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$6.2M |
| 2 |
JP Morgan Chase
New York
|
-$4.02M |
| 3 |
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
|
-$2.91M |
| 4 |
SC
Sophrosyne Capital
New York
|
-$2.68M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$2.44M |
